Detalles de la búsqueda
1.
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
Clin Infect Dis
; 78(3): 702-710, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882611
2.
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Clin Infect Dis
; 77(9): 1312-1317, 2023 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37280040
3.
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Clin Infect Dis
; 77(6): 875-882, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315296
4.
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change.
J Acquir Immune Defic Syndr
; 93(1): 42-46, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36724434
5.
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.
J Pediatric Infect Dis Soc
; 12(11): 581-585, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843384
6.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Lancet Child Adolesc Health
; 7(10): 718-727, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562418
7.
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Lancet HIV
; 9(9): e627-e637, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35868341
8.
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Lancet HIV
; 9(9): e638-e648, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055295
Resultados
1 -
8
de 8
1
Próxima >
>>